NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$16.59
Tradestie Score
63
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
+31.7%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$56.15
|
$3.26B | - | 57 | Compare |
|
VCYT
Veracyte, Inc.
|
$47.93
|
$2.85B | 32.9 | 54 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$132.55
|
$2.24B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.51
|
$2.22B | - | 66 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$139.92
|
$1.77B | - | 57 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$14.68
|
$1.56B | - | 55 | Compare |
|
NEOG
Neogen Corp
|
$12.19
|
$1.26B | - | 58 | Compare |
|
OPK
Opko Health Inc.
|
$1.63
|
$1.23B | - | 37 | Compare |
|
CDNA
CareDx, Inc.
|
$69.21
|
$798.40M | 34.1 | 23 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.10
|
$719.31M | - | 58 | Compare |
More NEO Analysis
Data updated: Oct 24, 2026 | Industry: Diagnostics & Research (SIC 8734)
36 stocks in this industry